Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2451-2455, May 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vredenburgh, J. J.
Right arrow Articles by Ball, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vredenburgh, J. J.
Right arrow Articles by Ball, E. D.

Reactivity of Anti-CD15 Monoclonal Antibody PM-81 with Breast Cancer and Elimination of Breast Cancer Cells from Human Bone Marrow by PM-81 and Immunomagnetic Beads1

James J. Vredenburgh, Wendy Simpson, Vincent A. Memoli and Edward D. Ball2

Departments of Medicine [E. D. B., J. J. V.], Microbiology [W. S.], and Pathology [V. A. M.], Dartmouth Medical School, Hanover, New Hampshire 03756

The CD15 carbohydrate antigen, lacto-N-fucopentaose III is expressed on a variety of human cancer cells including acute myeloid leukemia, small cell carcinoma of the lung, and colorectal carcinomas. We have found that cells from breast cancer cell lines and patient-derived tissue are strongly CD15 positive, as seen by binding to the PM-81 monoclonal antibody. In this report we show that monoclonal antibody PM-81 and immunomagnetic beads can remove breast cancer cells from bone marrow and thus be used as "purging" agents for autologous bone marrow transplantation. PM-81 and immunomagnetic beads removed up to 3 log of SK-BR-3 and MCF7 breast carcinoma cell line cells while minimally affecting normal hematopoietic progenitor cells. This technique may be useful for purging marrow for autologous bone marrow transplantation in breast cancer.

1 Supported in part by Grants CA 37868 from the National Cancer Institute, DHHS, and ACS IN-157 from the American Cancer Society. J. J. V. was a Tiffany Blake Fellow at the Dartmouth-Hitchcock Medical Center. E. D. B. is a Scholar of the Leukemia Society of America.

2 To whom requests for reprints should be addressed, at Department of Medicine, Dartmouth Medical School, Hanover, NH 03756.

Received 10/26/90. Accepted 2/22/91.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.